Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons

被引:13
作者
Bu, Jin [1 ]
Qiao, Xian [3 ]
He, Yunduan [2 ]
Liu, Jinsong [2 ]
机构
[1] Huazhong Univ Sci & Technol, Union Hosp, Dept Geriatr, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
[2] Huazhong Univ Sci & Technol, Union Hosp, Div Gastroenterol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
[3] Huazhong Univ Sci & Technol, Union Hosp, Dept Neurol, Tongji Med Coll, Wuhan 430022, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Parkinson disease; Constipation; Colonic transit; Colonic electrical stimulation; BOWEL MOVEMENT FREQUENCY; ALPHA-SYNUCLEIN; NONMOTOR SYMPTOMS; GASTROINTESTINAL DYSFUNCTION; DOPAMINERGIC-NEURONS; INTESTINAL MOTILITY; DESCENDING COLON; LATE-LIFE; CONSTIPATION; PREVALENCE;
D O I
10.1016/j.lfs.2019.116581
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Aims: The aims of this study were to investigate the effect of colonic electrical stimulation (CES) on delayed colonic transit in Parkinson's disease (PD) model induced by rotenone and its possible mechanisms. Main methods: Sprague-Dawley male rats were implanted with a pair of electrodes on the serosa at the proximal colon and rotenone was subcutaneously injected for 6 weeks to induce the PD model. Behavior activity, stool volume and open-field test were recorded during the injection. Colonic propulsion rate was measured 6 weeks after rotenone injection. Colon samples of all rats were collected for the measurement of phosphorylated alpha-synuclein, choline acetyltransferase (CHAT), neuronal nitric oxide synthase (nNOS), and tyrosine hydroxylase (TH). The protocols of control rats were the same as the PD rats except that no electrodes were implanted and no rotenone was injected. Key findings: (1) Rotenone-induced PD rats demonstrated weight loss, significant decrease of the dopaminergic neurons in substantia nigra, and impairment of colon movement (2) CES significantly accelerated the delayed colonic transmit (91.67 +/- 5.58% vs 51.33 +/- 4.18%), superior to Macrogol-4000. (3) CES significantly upregulated the expression of CHAT, nNOS and TH protein in colon of PD rats. (4) In colon of PD rats, the phosphorylated alpha-synuclein was significantly upregulated, but CES had no significant effect on phosphorylated alpha-synuclein. Significance: Our data show that CES can normalize the delayed colonic transit and this normalization may attribute to affecting enteric excitatory and inhibitory neurons.
引用
收藏
页数:10
相关论文
共 49 条
  • [1] Bowel movement frequency in late-life and incidental Lewy bodies
    Abbott, Robert D.
    Ross, G. Webster
    Petrovitch, Helen
    Tanner, Caroline M.
    Davis, Daron G.
    Masaki, Karnal H.
    Launer, Lenore J.
    Curb, J. David
    White, Lon R.
    [J]. MOVEMENT DISORDERS, 2007, 22 (11) : 1581 - 1586
  • [2] Loss of enteric dopaminergic neurons and associated changes in colon motility in an MPTP mouse model of Parkinson's disease
    Anderson, Grant
    Noorian, All Reza
    Taylor, Georgia
    Anitha, Mallappa
    Bernhard, Doug
    Srinivasan, Shanthi
    Greene, James G.
    [J]. EXPERIMENTAL NEUROLOGY, 2007, 207 (01) : 4 - 12
  • [3] Phosphorylation of Ser-129 is the dominant pathological modification of α-synuclein in familial and sporadic Lewy body disease
    Anderson, John P.
    Walker, Donald E.
    Goldstein, Jason M.
    de laat, Rian
    Banducci, Kelly
    Caccavello, Russell J.
    Barbour, Robin
    Huang, Jiping
    Kling, Kristin
    Lee, Michael
    Diep, Linnea
    Keim, Pamela S.
    Shen, Xiaofeng
    Chataway, Tim
    Schlossmacher, Michael G.
    Seubert, Peter
    Schenk, Dale
    Sinha, Sukanto
    Gai, Wei Ping
    Chilcote, Tamie J.
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (40) : 29739 - 29752
  • [4] The Priamo Study: A Multicenter Assessment of Nonmotor Symptoms and Their Impact on Quality of Life in Parkinson's Disease
    Barone, Paolo
    Antonini, Angelo
    Colosimo, Carlo
    Marconi, Roberto
    Morgante, Letterio
    Avarello, Tania P.
    Bottacchi, Eugenio
    Cannas, Antonino
    Ceravolo, Gabriella
    Ceravolo, Roberto
    Cicarelli, Giulio
    Gaglio, Roberto M.
    Giglia, Rosa M.
    Iemolo, Francesco
    Manfredi, Michela
    Meco, Giuseppe
    Nicoletti, Alessandra
    Pederzoli, Massimo
    Petrone, Alfredo
    Pisani, Antonio
    Ponfieri, Francesco E.
    Quatrale, Rocco
    Ramat, Silvia
    Scala, Rosanna
    Volpe, Giuseppe
    Zappulla, Salvatore
    Bentivoglio, Anna Rita
    Stocchi, Fabrizio
    Trianni, Giorgio
    Del Dotto, Paolo
    [J]. MOVEMENT DISORDERS, 2009, 24 (11) : 1641 - 1649
  • [5] Diagnostic utility of gut α-synuclein in Parkinson's disease: A systematic review and meta-analysis
    Bu, Jin
    Liu, Jinsong
    Liu, Kun
    Wang, Zhaohui
    [J]. BEHAVIOURAL BRAIN RESEARCH, 2019, 364 : 340 - 347
  • [6] Management of constipation in patients with Parkinson's disease
    Carrasco, Anna J. Pedrosa
    Timmermann, Lars
    Pedrosa, David J.
    [J]. NPJ PARKINSONS DISEASE, 2018, 4
  • [7] Gastrointestinal manifestations in Parkinson's disease: prevalence and occurrence before motor symptoms
    Cersosimo, Maria G.
    Raina, Gabriela B.
    Pecci, Cristina
    Pellene, Alejandro
    Calandra, Cristian R.
    Gutierrez, Cristiam
    Micheli, Federico E.
    Benarroch, Eduardo E.
    [J]. JOURNAL OF NEUROLOGY, 2013, 260 (05) : 1332 - 1338
  • [8] Electrical therapies for gastrointestinal motility disorders
    Chen, Jiande D. Z.
    Yin, Jieyun
    Wei, Wei
    [J]. EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2017, 11 (05) : 407 - 418
  • [9] Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction
    Cheng, Chunwei
    Tan, Jun
    Qian, Wei
    Zhang, Lei
    Hou, Xiaohua
    [J]. LIFE SCIENCES, 2018, 209 : 157 - 166
  • [10] Dickson DW, 2009, LANCET NEUROL, V8, P1150, DOI 10.1016/S1474-4422(09)70238-8